{
    "eid": "2-s2.0-85071736670",
    "title": "Screening for non-alcoholic fatty liver disease in community setting: A cohort study using controlled attenuation parameter-transient elastography",
    "cover-date": "2020-04-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Gastroenterology",
            "@code": "2715",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Hepatology",
            "@code": "2721",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "community-based",
        "controlled attenuation parameter",
        "liver fibrosis",
        "non-alcoholic fatty liver disease",
        "transient elastography"
    ],
    "authors": [
        "Nicha Teeratorn",
        "Panida Piyachaturawat",
        "Kessarin Thanapirom",
        "Roongruedee Chaiteerakij",
        "Kanokwan Sonsiri",
        "Piyawat Komolmit",
        "Pisit Tangkijvanich",
        "Rungsun Rerknimitr",
        "Leon Adams",
        "Sombat Treeprasertsuk"
    ],
    "citedby-count": 7,
    "ref-count": 24,
    "ref-list": [
        "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the Global Burden of Disease Study 2015",
        "Asian consensus on the relationship between obesity and gastrointestinal and liver diseases",
        "Prevalence of nonalcoholic fatty liver disease in mainland of China: a meta-analysis of published studies",
        "Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography",
        "Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy",
        "Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes",
        "Diagnosis and evaluation of nonalcoholic fatty liver disease",
        "Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease",
        "Burden of non-alcoholic fatty liver disease in Australia",
        "Repeating measurements by transient elastography in non-alcoholic fatty liver disease patients with high liver stiffness",
        "Transient elastography (FibroScan\u00ae) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease\u2014where do we stand?",
        "Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan\u00ae",
        "Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: the Rotterdam study",
        "Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis",
        "Nonobese fatty liver disease",
        "Vibration-controlled transient elastography to assess fibrosis and steatosis in patients with nonalcoholic fatty liver disease",
        "Obesity and gastrointestinal liver disorders in Japan",
        "Factors associated with significant liver fibrosis assessed using transient elastography in general population",
        "Screening for liver fibrosis in the general population: a call for action",
        "Prevalence and seroincidence of hepatitis B and hepatitis C infection in high risk people who inject drugs in China and Thailand",
        "Prevalence, risk factors, and impact of isolated antibody to hepatitis B core antigen and occult hepatitis B virus infection in HIV-1-infected pregnant women",
        "Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update",
        "Hepatitis B and hepatitis C in southeast and southern Asia: challenges for governments",
        "Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Perth",
            "@id": "60031806",
            "affilname": "The University of Western Australia",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031806",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60031780",
            "affilname": "Thai Red Cross Agency",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Phisanulok",
            "@id": "60011546",
            "affilname": "Buddhachinaraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011546",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Division of Gastroenterology, Faculty of Medicine, Chulalongkorn UniversityWe",
        "Fatty Liver Unit",
        "Chulalongkorn University"
    ]
}